Close

content

FDA approves new indication for Novartis drug Afinitor® for progressive, nonfunctional GI and lung neuroendocrine tumors

Novartis announced that the United States FDA approved Afinitor® tablets for the treatment of adult patients with progressive, well-differentiated, nonfunctional neuroendocrine tumors of gastrointestinal...

Mersana Therapeutics and Takeda Expand Partnership to Advance Development of Fleximer Antibody-Drug

Mersana Therapeutics and Takeda Pharmaceutical Company Limited announced that they have entered a new strategic partnership granting Takeda rights to Mersana’s lead product candidate,...

U.S. FDA Accepts Filing Of Cardiovascular Outcomes Data For Jardiance® (Empagliflozin)

The U.S. FDA accepted a supplemental New Drug Application for Jardiance based on cardiovascular risk reduction data from the landmark EMPA-REG OUTCOME® trial.  ...

FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment

Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc announced that the U.S. FDA granted approval for Basaglar 100 units/mL. BASAGLAR is a long-acting...

Beximco Pharma forms JV with Malaysia-based BioCare Manufacturing

Beximco Pharmaceuticals Limited the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, announces the creation of a joint venture with BioCare Manufacturing...

Alcon spotlights DAILIES TOTAL1® contact lenses in national television campaign

TV spot showcases the science behind the ultimate breathability and comfort of DAILIES TOTAL1® contact lenses Fort Worth, Texas- Alcon, the...

Lilly to Present New Clinical Data at 75th American Diabetes Association® Scientific Sessions

New clinical data demonstrating the range of treatment options represented in Lilly's diabetes portfolio will be presented in 79 abstracts on June 5-9, at...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read